response to Pomodoro - I notice your post was on the 28th Dec...

response to Pomodoro - I notice your post was on the 28th Dec when the share price was $25.05. The valuations given by the brokers were not that massive relative to the $25 share price at the time, and reflected only a small increase relative to the potential value of 2591. I wonder why the brokers were so conservative in their fair price estimation, and what basis they used on to come up with such a low ball estimation. I wonder if all they do is look at the recent trend of share price and add a couple of $ to the most recent price. I've got a much higher valuation of $115 per share based on the net present value of future discounted net cash flows for the next 10 years, assuming success of 2591 to commercialisation in 4 indications it's currently being tested for, but excluding sales of 2591 outside of the USA, and assuming current growth trends of Daybue in the USA and in the rest of the world commencing in 2 years' time (in 2026 CY). So I believe my estimation of the share price is still conservative with plenty of upside.